Sublingual Photobiomodulation in Parkinson's Disease

University of Nove de Julho

Status

Unknown

Conditions

Parkinson Disease

Treatments

Device: placebo photobiomodulation

Device: photobiomodulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04028817

sublingual photobiomodulation

Details and patient eligibility

About

This study evaluates the use of photobiomodulation in the treatment of patients with Parkinson's disease. Half of participants will receive treatment with low level laser therapy and exercises in combination, while the other half will receive a placebo laser combined with exercises.

Enrollment

40 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients with Parkinson's disease diagnosed with the criteria of the UK Parkinsons' Disease Society Brain Bank Clinical Diagnostic Criteria
In the stages I to III of the disease according to Hoehn & Yahr's Parkinson's disease staging scale - modified;
Individuals of both sexes,
with more than 50 years
who sign the informed consent form

Exclusion criteria

patients who present some adverse event during the development of the study,
Who have another associated neurodegenerative disease,
Have blood dyscrasia, HIV, heart failure, hepatic or renal insufficiency, infections, neoplasias, respiratory disorders, hypophysis and hypothalamus problems.
Who fail to understand or perform procedures correctly because of physical and mental limitations.